PRAXIS PRECISION MEDICINES, INC. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PRAXIS PRECISION MEDICINES, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-06-30 was $809.00K, a 175.17% increase year-over-year.
- PRAXIS PRECISION MEDICINES, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-06-30 was $294.00K, a 5.47% decline year-over-year.
- PRAXIS PRECISION MEDICINES, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2024-12-31 was $233.00K, a 119.81% increase year-over-year.
- PRAXIS PRECISION MEDICINES, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2024-06-30 was $311.00K, a 49.52% increase year-over-year.
- PRAXIS PRECISION MEDICINES, INC. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $717.00K, a 31.80% increase from fiscal 2024.
- PRAXIS PRECISION MEDICINES, INC. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $544.00K, a 73.25% increase from fiscal 2023.
- PRAXIS PRECISION MEDICINES, INC. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $314.00K.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-06-30 | $809.00K 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $717.00K 10-K · filed 2026-02-19 | |
| 2025-06-30 | $294.00K 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $233.00K 10-K · filed 2025-02-28 | $544.00K 10-K · filed 2026-02-19 |
| 2024-06-30 | $311.00K 10-Q · filed 2025-11-05 | |
| 2023-12-31 | $106.00K 10-K · filed 2025-02-28 | $314.00K 10-K · filed 2026-02-19 |
| 2023-06-30 | $208.00K 10-K · filed 2025-02-28 | |
| 2022-12-31 | $163.00K 10-K · filed 2024-03-05 | |
| 2022-06-30 | $454.00K 10-Q · filed 2023-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |